HighTower Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$389K Sell
30,832
-8,444
-21% -$105K ﹤0.01% 2961
2026
Q2
$569K Buy
39,276
+5,018
+15% +$67.7K ﹤0.01% 2626
2026
Q1
$474K Buy
34,258
+19,659
+135% +$274K ﹤0.01% 2768
2025
Q4
$205K Sell
14,599
-2,011
-12% -$28.2K ﹤0.01% 3356
2025
Q3
$232K Buy
16,610
+2,982
+22% +$42.9K ﹤0.01% 3241
2025
Q2
$205K Sell
13,628
-1,849
-12% -$26.4K ﹤0.01% 3261
2025
Q1
$204K Sell
15,477
-14,445
-48% -$199K ﹤0.01% 3169
2024
Q4
$472K Buy
+29,922
New +$450K ﹤0.01% 2519
2023
Q3
– Sell
-138,745
Closed -$1.76M – 3721
2023
Q2
$1.76M Buy
+138,745
New +$1.62M ﹤0.01% 1426
2020
Q2
– Sell
-198,780
Closed -$1.61M – 2519
2020
Q1
$1.61M Buy
+198,780
New +$1.66M 0.01% 820
2019
Q1
– Sell
-40,655
Closed -$305K – 2399
2018
Q4
$305K Buy
+40,655
New +$286K ﹤0.01% 1594
2017
Q1
– Sell
-73,365
Closed -$667K – 2150
2016
Q4
$667K Sell
73,365
-1,735
-2% -$16.1K 0.01% 1143
2016
Q3
$698K Sell
75,100
-88,955
-54% -$849K 0.01% 1074
2016
Q2
$1.71M Sell
164,055
-6,650
-4% -$60.9K 0.02% 675
2016
Q1
$1.56M Buy
+170,705
New +$1.53M 0.01% 825
2015
Q4
– Sell
-196,100
Closed -$2.48M – 2123
2015
Q3
$2.48M Sell
196,100
-1,730
-0.9% -$21.5K 0.03% 541
2015
Q2
$2.18M Buy
197,830
+57,975
+41% +$640K 0.04% 514
2015
Q1
$1.6M Buy
139,855
+1,875
+1% +$19.9K 0.02% 659
2014
Q4
$1.39M Buy
137,980
+19,650
+17% +$207K 0.02% 697
2014
Q3
$1.24M Buy
118,330
+27,590
+30% +$259K 0.02% 699
2014
Q2
$783K Buy
90,740
+24,040
+36% +$202K 0.01% 900
2014
Q1
$586K Buy
+66,700
New +$580K 0.01% 924
2013
Q3
– Sell
-59,325
Closed -$589K – 1432
2013
Q2
$589K Buy
+59,325
New +$433K 0.02% 752

Other funds holding RDY

HighTower Advisors's RDY Position: Q3 2026 in Review

HighTower Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 21% in Q3 2026, selling an estimated $105K and leaving 30,832 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2961.

HighTower Advisors first reported a position in RDY in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.48M in Q3 2015. 236 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • HighTower Advisors held 30,832 shares of Dr. Reddy's Laboratories worth $389K as of Q3 2026.
  • HighTower Advisors sold 8,444 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $105K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2961 holding.
  • HighTower Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 23 quarters since.
  • HighTower Advisors's Dr. Reddy's Laboratories position peaked at $2.48M in Q3 2015.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.